Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Novartis ArgentinaNovartis Argentina
VS
Alembic Pharmaceuticals LimitedAlembic Pharmaceuticals Limited
Novartis Argentina

Novartis Argentina

undefined, Buenos Aires, undefined, undefined, AR

Last Update: 07/01/2026

View Profile
752/1000Fair

Novartis está reimaginando la medicina para mejorar y prolongar la vida de las personas. Como empresa líder mundial en medicamentos, utilizamos ciencia innovadora y tecnologías digitales para crear tratamientos transformadores en áreas de gran necesidad médica. En nue...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:101
Subsidiaries:40
12-month incidents
0
Known data breaches
0
Attack type number
0
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Alembic Road, Vadodara, 390003, IN

Last Update: 20/09/2026

View Profile
Between 750 and 799
http://www.alembic-india.com
759/1000Fair

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is t...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,168
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Novartis Argentina

Novartis Argentina

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Argentina in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Alembic Pharmaceuticals Limited in 2026.

Incidents

Incident History - Novartis Argentina (X = Date, Y = Severity)

Novartis Argentina cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Alembic Pharmaceuticals Limited (X = Date, Y = Severity)

Alembic Pharmaceuticals Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Novartis Argentina

Novartis Argentina

Incidents
No explicit notable incidents reported.
Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Incidents
No explicit notable incidents reported.

FAQ

Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one has the best AI Cybersecurity Score ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one has experienced more cyber incidents in the past ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one has experienced more cyber incidents this year ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one has experienced at least one ransomware attack ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one has experienced at least one data breach ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one has experienced at least one targeted cyberattack ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one has experienced at least one vulnerability ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one holds the most compliance certifications ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one holds the fewest compliance certifications ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one has the most subsidiaries ?
Between Novartis Argentina company and Alembic Pharmaceuticals Limited company, which one has the largest number of employees ?
Between Novartis Argentina and Alembic Pharmaceuticals Limited, which company holds both SOC 2 Type 1 certifications ?
Between Novartis Argentina and Alembic Pharmaceuticals Limited, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Novartis Argentina or Alembic Pharmaceuticals Limited ?
Which company is PCI DSS compliant - Novartis Argentina or Alembic Pharmaceuticals Limited ?
Between Novartis Argentina and Alembic Pharmaceuticals Limited, which company complies with HIPAA regulations for healthcare data ?
Between Novartis Argentina and Alembic Pharmaceuticals Limited, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-93892
SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-93891
SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 7.6)
CVSS3
Base Score: 7.6
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:N/A:L
IMPACT SCORE
4.7
EXPLOITABILITY
2.3
CVE-2026-92832
SUMMARY

IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 5.1)
CVSS3
Base Score: 5.1
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
2.5
CVE-2026-85457
SUMMARY

IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-84418
SUMMARY

IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.

PUBLISHED
Date2026-10-12
UPDATED
Date2026-10-12
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2